Raoul Tibes, MD, PhD
Advertisement
Articles by Raoul Tibes, MD, PhD
Advertisement
Latest Updated Articles
Dr. Raoul Tibes Discusses FLT3 Inhibitors in AMLJuly 28th 2016
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
2
Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC
3
Novel Analysis Reveals Millions of Life-Years Saved by Blood Cancer Treatments
4
Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC
5